U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
TAT-NR2B9C is a synthetic peptide fusion of the nine C-terminal residues of the NR2B subunit of the N-methyl-D-aspartate (NMDA) receptor and the cell membrane protein transduction domain of the HIV-1 tat protein. It is a postsynaptic density protein-95 (PSD95) inhibitor with neuroprotective properties. It is under development for the treatment of acute stroke and acute cerebral ischemia.

CNS Activity

Curator's Comment: Low brain penetrability.

Approval Year

PubMed

PubMed

TitleDatePubMed
PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors.
2007 Sep 12
Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat.
2017 Jan
Discovery and development of NA-1 for the treatment of acute ischemic stroke.
2018 May

Sample Use Guides

2.6 mg/kg as a single intravenous infusion over 10 +/-1 minutes.
Route of Administration: Intravenous
Substance Class Protein
Created
by admin
on Sat Dec 16 09:40:24 GMT 2023
Edited
by admin
on Sat Dec 16 09:40:24 GMT 2023
Protein Sub Type
Sequence Type COMPLETE
Record UNII
D45TI2TWMA
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NERINETIDE
USAN   INN  
Official Name English
nerinetide [INN]
Common Name English
NA-1
Code English
FN023
Code English
TAT-NR2B9C
Common Name English
FN-023
Code English
NERINETIDE [USAN]
USAN  
Common Name English
L-VALINE, L-TYROSYLGLYCYL-L-ARGINYL-L-LYSYL-L-LYSYL-L-ARGINYL-L-ARGINYL-L-GLUTAMINYL-L-ARGINYL-L-ARGINYL-L-ARGINYL-L-LYSYL-L-LEUCYL-L-SERYL-L-SERYL-L-ISOLEUCYL-L-.ALPHA.-GLUTAMYL-L-SERYL-L-.ALPHA.-ASPARTYL-
Systematic Name English
L-TYROSYLGLYCYL-L-ARGINYL-L-LYSYL-L-LYSYL-L-ARGINYL-L-ARGINYL-L-GLUTAMINYL-L-ARGINYL-L-ARGINYL-L-ARGINYL-L-LYSYL-L-LEUCYL-L-SERYL-L-SERYL-L-ISOLEUCYL-L-.ALPHA.-GLUTAMYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-VALINE
Systematic Name English
TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-LYS-LEU-SER-SER-ILE-GLU-SER-ASP-VAL
Systematic Name English
H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-LYS-LEU-SER-SER-ILE-GLU-SER-ASP-VAL-OH
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 377812
Created by admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
FDA ORPHAN DRUG 412713
Created by admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C170212
Created by admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
PRIMARY
INN
10857
Created by admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
PRIMARY
FDA UNII
D45TI2TWMA
Created by admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
PRIMARY
USAN
GH-179
Created by admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
PRIMARY
CAS
500992-11-0
Created by admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
PRIMARY
DRUG BANK
DB12595
Created by admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
PRIMARY
PUBCHEM
44568939
Created by admin on Sat Dec 16 09:40:24 GMT 2023 , Edited by admin on Sat Dec 16 09:40:24 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
neurological agent
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER AVERAGE(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL